SKINBIOTHERAPEUTICS PLC

Active Newcastle Upon Tyne

Other human health activities

41 employees website.com
Life sciences and medical technology Other human health activities
S

SKINBIOTHERAPEUTICS PLC

Other human health activities

Founded 10 Jun 2015 Active Newcastle Upon Tyne, England 41 employees website.com
Life sciences and medical technology Other human health activities

Previous Company Names

SKINBIOTHERAPEUTICS LTD 23 Dec 2016 — 23 Dec 2016
SKINBIOTIX LTD 10 Jun 2015 — 23 Dec 2016
Accounts Submitted 16 Dec 2025 Next due 31 Dec 2026 8 months remaining
Confirmation
Net assets £9M £6M 2025 year on year
Total assets £12M £7M 2025 year on year
Total Liabilities £3M £462K 2025 year on year
Charges 1
1 outstanding

Contact & Details

Contact

Registered Address

The Core Bath Lane Newcastle Helix Newcastle Upon Tyne NE4 5TF England

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for SKINBIOTHERAPEUTICS PLC (09632164), an active life sciences and medical technology company based in Newcastle Upon Tyne, England. Incorporated 10 Jun 2015. Other human health activities. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2025
Type Total Exemption Full
Next accounts 31 December 2026
Due by 30 September 2027 9 months

Balance Sheet & P&L (2016–2025)

Cash in Bank

£4.78M

Increased by £3.98M (+497%)

Net Assets

£9.42M

Increased by £6.45M (+217%)

Total Liabilities

£2.71M

Increased by £462.00k (+21%)

Turnover

£4.64M

Increased by £3.42M (+279%)

Employees

41

Increased by 26 (+173%)

Debt Ratio

22%

Decreased by 21 (-49%)

Financial History

Revenue, profit, EBITDA and key financial figures

2025
Dec Year End
2024
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Funding Rounds 5

Investors (1)

Investor NameInvestor SinceParticipating Rounds
Investor 1Oct 2024Growth/Late Stage

Share Capital

Share Capital

Share allotments and capital structure

23 Allotments 179,764,977 Shares £15448693.43m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
13 Feb 2026259,472£23k£0.09
22 Jan 2026129,736£12k£0.09
24 Jun 202524,704,836£4.20m£0.17
1 May 20251,099,244£225k£0.204
8 Apr 20251,000,000£204k£0.204

Officers

Officers

1 active 2 resigned
Status
Catherine Denise PrescottDirectorBritishEngland651 Mar 2017Active

Shareholders

Shareholders (16)

Gresham House Asset Management Limited
10.7%
Optibiotix Health Plc
8.5%

Persons with Significant Control

Persons with Significant Control (0)

0 Active 1 Ceased

Optibiotix Health Plc

Ceased 2 Nov 2020

Ceased

Group Structure

Group Structure

SKINBIOTHERAPEUTICS PLC Current Company
SKINBIOTIX LIMITED united kingdom
MEDIBIOTIX LIMITED united kingdom
DERMATONICS LTD united kingdom
AXISBIOTIX LIMITED united kingdom
CLEANBIOTIX LIMITED united kingdom
PHARMABIOTIX LIMITED united kingdom

Charges

Charges

1 outstanding

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
13 Apr 2026MortgageMortgage Create With Deed With Charge Number Charge Creation Date
9 Mar 2026OfficersAppointment of Miss Rachel Lisa Parsonage as director on 9 Mar 2026
13 Feb 2026OfficersTermination of Stuart Ashman as director on 13 Feb 2026
13 Feb 2026CapitalAllotment of shares (GBP 2,591,686.71) on 13 Feb 2026
26 Jan 2026CapitalAllotment of shares (GBP 2,589,091.99) on 22 Jan 2026
13 Apr 2026 Mortgage

Mortgage Create With Deed With Charge Number Charge Creation Date

9 Mar 2026 Officers

Appointment of Miss Rachel Lisa Parsonage as director on 9 Mar 2026

13 Feb 2026 Officers

Termination of Stuart Ashman as director on 13 Feb 2026

13 Feb 2026 Capital

Allotment of shares (GBP 2,591,686.71) on 13 Feb 2026

26 Jan 2026 Capital

Allotment of shares (GBP 2,589,091.99) on 22 Jan 2026

Recent Activity

Latest Activity

Mortgage Create With Deed With Charge Number Charge Creation Date

2 weeks ago on 13 Apr 2026

Appointment of Miss Rachel Lisa Parsonage as director on 9 Mar 2026

1 months ago on 9 Mar 2026

Termination of Stuart Ashman as director on 13 Feb 2026

2 months ago on 13 Feb 2026

Allotment of shares (GBP 2,591,686.71) on 13 Feb 2026

2 months ago on 13 Feb 2026

Allotment of shares (GBP 2,589,091.99) on 22 Jan 2026

3 months ago on 26 Jan 2026